期刊文献+

大鼠牙齿移动过程中牙周组织MMP-2的表达变化 被引量:2

Change of gelatinase-A expression and distribution in the periodontal tissues of rats during tooth movement
下载PDF
导出
摘要 目的:观察大鼠正畸牙齿移动过程中基质金属蛋白酶-2(MMP-2)的表达和分布变化。方法:选用40只雄性SD大鼠,于加力后0 d、3 d、7 d、14 d、21 d处死大鼠,免疫组化法检测明胶酶-2(MMP-2)的表达,计算平均光密度(OD)和积分光密度(IOD)。结果:牙齿移动后牙周膜两侧MMP-2表达增加,破骨细胞、破牙本质细胞、骨细胞、成纤维细胞和部分成骨细胞、成牙本质细胞染色阳性。OD表现动态变化,7 d最低,而后缓慢升高。加力后IOD逐渐升高,7 d达到顶峰而后缓慢下降,21 d时仍维持在高水平。结论:牙齿移动时MMP-2呈规律性变化,与牙齿正畸骨改建关系密切。 Objective: To observe the expression and distribution of gelatinase-A (MMP-2) in the periodontal tissues of rats during tooth movement. Methods: Forty male Sprague-Dawley rats were used. The animals were sacrificed after 0d, 3d, 7d, 14d and 21 days respectively. Immunohistochemistry was applied to localize and examine the expression of gelatinase-A (MMP-2) in periodontal tissue. The average optical density (OD) and integrated optical density (IOD) were calculated. Results: In tooth movement groups, the MMP-2 expression increased and was observed on both sides periodontium of movement tooth. Osteoclast, cementoblast, osteocyte, fibroblast, a part of osteoblast and cementoblast appear positive. Dynamic changes of OD occurred. OD reached the minimum on the 7th day and then increased slowly. IOD increased steadily, up to the peak on the 7th day, and then decreased, which still remained a high level on the 21 st day. Conclusion:MMP-2's activity changes regularly, in close relation with bone remodeling during the orthodontic tooth movement.
出处 《军医进修学院学报》 CAS 北大核心 2007年第3期220-222,共3页 Academic Journal of Pla Postgraduate Medical School
关键词 正畸学 牙移动 明胶酶-2 免疫组织化学法 大鼠 orthodontics tooth movement gelatinase-A immunohistochemistry rat
  • 相关文献

参考文献11

  • 1樊明文.口腔生物学[M].北京:人民卫生出版社,2001:320-325.
  • 2杨春花,黄烽.炎性关节疾病与基质金属蛋白酶-3[J].军医进修学院学报,2005,26(2):147-149. 被引量:6
  • 3Redlich M,Reichenberg E,Harari D,et al.The effect of mechanical force on mRNA levels of collagenase,collagen type Ⅰ,and tissue inhibitors of metalloproteinases in gingivae of dogs[J].J Dental Research,2001,80:2080-2084.
  • 4金钫,段银钟,李潇.大鼠牙齿移动过程中牙周组织中基质金属蛋白酶-2的表达和分布[J].牙体牙髓牙周病学杂志,2001,11(3):157-159. 被引量:9
  • 5Takahashi I,Nishimara M,Onodera K,et al.Expreession of MMP-8 and MMP-13 genes in the periodontal ligament during tooth movement in rats[J].J Dental Research,2003,82(8):646-651.
  • 6Ingman T,Apajalahti S,Mantyla P,et al.Matrix metalloproteinase-1 and -8 in gingival crevicular fluid during orthodontic tooth movement:a pilot study during 1 month of follow-up after fixed appliance activation[J].European J Orthodontics,2005,27(2):202-207.
  • 7Holliday LS,Vakani A,Archer L,et al.Effects of matrix metalloproteinase inhibitors on bone resorption and orthodontic tooth movement[J].J Dental Research,2003,82(9):687-691.
  • 8Creemers LB,Jansen ID,Docherty AJ,et al.Gelatinase A (MMP-2) and cysteine proteinases are essential for the degradation of collagen in soft connective tissue[J].Matrix Biol,1998,17(1):35-46.
  • 9Rice DP,Kim HJ,Thesleff I.Detection of gelatinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development[J].Bone,1997,21(6):479-486.
  • 10Uematsu S,Mogi M,Deguchi T.Interleukin (IL)-1 beta,IL-6,tumor necrosis factor-alpha,epidermal growth factor,and beta 2-microglobulin levels are elevated in gingival crevicular fluid during human orthodontic tooth movement[J].J Dental Research,75:562-567.

二级参考文献15

  • 1Martel-Pelletier J, Welsch DJ, Pelletier JP. Metalloproteinases and inhibitors in arthritic diseases [ J ]. Best Pract Res Clin Rheumatol, 2001, 15:805-829.
  • 2Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases, structure, function, and biochemistry[J].Cite Res, 2003, 92: 827-839.
  • 3Ribbens C, Andre B, Kaye O, et al. Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not [ J]. Rheumatology, 2000, 39 : 1357-1365.
  • 4Ichikawa Y, Yamada C, Horiki T, et al. Serum matrix metalloproteinase-3 and fibrin degradation product levels correlate with clinical disease activity in rheumatoid arthritis [J]. Clin Exp Rheumatol, 1998, 16(5): 533-540.
  • 5Keyszer G, Lambiri I, Nagel R, et al. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1) , and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers [J]. J Rheumatol, 1999, 26(2) :251-258.
  • 6Ribbens G, Andre B, Jaspar JM, et al. Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis [ J ]. J Rheumatol, 2000, 27 :888-893.
  • 7Yarnanaka H, Matsuda Y, Tanaka M, et al. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis [J]. Arthritis Rheum, 2000, 43: 825-828.
  • 8Kane D, Jensen L, Grehan S, et al. Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction [ J ]. J Rheumatol, 2004, 31 : 1274-1280.
  • 9Ribbens C, Martin y Porras M, Franchimont N, et al. Increased matrix metaUoproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment [ J ]. Ann Rheum Dis, 2002, 61:161-166.
  • 10Maksymowych WP, Jhangri GS, Lambert RG, et al. Infliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safety [J]. J Rheumatol, 29: 959-965.

共引文献13

同被引文献40

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部